Global Cancer Diagnostics Market, By Type (Endometrial Cancer, Bladder Cancer, Breast Cancer, Colon and Rectal Cancer, Kidney Cancer, Leukemia, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma), By Application (Imaging, Tumor Biomarkers Tests, Biopsy, Immunohistochemistry, Liquid Biopsy, In Situ Hybridization), By End-User (Hospitals, Imaging Centers, Diagnostic Laboratories, Cancer Research Institutes. and Documentation System), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027
Published:
June 2021
Report Code:
BWC19374
Available Format:
PDF PDF Icon
Pages:
145

global cancer diagnostics market bwc19374

1.  Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary and Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary and Secondary Sources

2.3. Breakdown of Primary Research Respondents

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Industry Participants

2.5. Key Questionnaire asked during Primary Interviews

2.6. Key Primary Responses

2.7. Market Size Estimation

2.8. Assumption for the Study

2.9. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Cancer Diagnostics Market – Industry Insights

4.1. DROC Analysis

4.1.1.   Growth Drivers

4.1.2.   Restraints

4.1.3.   Opportunity

4.1.4.   Challenges

4.2. Recent Developments / Technical Landscape

4.3. Regulatory Framework

4.4. Porter’s Five Forces Analysis

4.5. Value Chain Analysis

4.6. Strategic Outlook

5.    Global Cancer Diagnostics Market Overview

5.1. Market Estimates & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Million)

5.1.2.   By Volume (Thousand Units)

5.2. Market Share & Forecast

5.2.1.   By Type

5.2.1.1. Endometrial Cancer

5.2.1.2. Bladder Cancer

5.2.1.3. Breast Cancer

5.2.1.4. Colon and Rectal Cancer

5.2.1.5. Kidney Cancer

5.2.1.6. Leukemia

5.2.1.7. Pancreatic Cancer

5.2.1.8. Prostate Cancer

5.2.1.9. Thyroid Cancer

5.2.1.10.              Liver-Lung Cancer

5.2.1.11.              Melanoma

5.2.1.12.              Non-Hodgkin Lymphoma

5.2.2.   By Application

5.2.2.1. Imaging

5.2.2.2. Tumor Biomarkers Tests

5.2.2.3. Biopsy

5.2.2.4. Immunohistochemistry

5.2.2.5. Liquid Biopsy

5.2.2.6. In Situ Hybridization

5.2.3.   By End-User

5.2.3.1. Hospitals

5.2.3.2. Imaging Centers

5.2.3.3. Diagnostic Laboratories

5.2.3.4. Cancer Research Institutes. and Documentation System

5.2.4.   By Region

5.2.4.1. North America

5.2.4.2. Europe

5.2.4.3. Asia-Pacific (APAC)

5.2.4.4. Latin America (LATAM)

5.2.4.5. Middle-East & Africa (MEA)

6.    North America Cancer Diagnostics Market Overview

6.1. Market Size and Forecast

6.1.1.   By Value (USD Million), 2017-2027

6.2. Market Share and Forecast

6.2.1.   By Type

6.2.2.   By Application

6.2.3.   By End-User

6.2.4.   By Country

6.2.4.1. U.S.

6.2.4.2. Canada

7.    Europe Cancer Diagnostics Market Overview

7.1.     Market Size and Forecast

7.1.1.   By Value (USD Million), 2017-2027

7.2.     Market Share and Forecast

7.2.1.   By Type

7.2.2.   By Application

7.2.3.   By End-User

7.2.4.   By Country

7.2.4.1.   Germany

7.2.4.2.   U.K.

7.2.4.3.   France

7.2.4.4.   Italy

7.2.4.5.   Spain

7.2.4.6.   Russia

7.2.4.7.   Netherlands

7.2.4.8.   Rest of Europe

8.    APAC Cancer Diagnostics Market Overview

8.1.     Market Size and Forecast

8.1.1.   By Value (USD Million), 2017-2027

8.2.     Market Share and Forecast

8.2.1.   By Type

8.2.2.   By Application

8.2.3.   By End-User

8.2.4.   By Country

8.2.4.1.   China

8.2.4.2.   India

8.2.4.3.   Japan

8.2.4.4.   South Korea

8.2.4.5.   Rest of APAC

9.    LATAM Cancer Diagnostics Market Overview

9.1.     Market Size and Forecast

9.1.1.   By Value (USD Million), 2017-2027

9.2.     Market Share and Forecast

9.2.1.   By Type

9.2.2.   By Application

9.2.3.   By End-User

9.2.4.   By Country

9.2.4.1.   Mexico

9.2.4.2.   Brazil

9.2.4.3.   Rest of LATAM

10.MEA Cancer Diagnostics Market Overview

10.1.   Market Size and Forecast

10.1.1.                By Value (USD Million), 2017-2027

10.2.   Market Share and Forecast

10.2.1.                By Type

10.2.2.                By Application

10.2.3.                By End-User

10.2.4.                By Country

10.2.4.1.              Saudi Arabia

10.2.4.2.              UAE

10.2.4.3.              South Africa

10.2.4.4.              Rest of Europe

11.Competitive Landscape

11.1.1.                List of Key Producers and Their Offerings

11.1.2.                Market Share / Ranking Analysis (2020)

11.1.3.                Competitive Benchmarking, By Operating Parameters

12.COVID-19 Impact

12.1.             Future Impact

12.2.             Key Developments during COVID-19

12.3.             Impact on Market

12.3.1.                Different Scenario

12.3.2.                Impact on Companies

12.4.             Regional Impact

13.Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

13.1.             GE Healthcare

13.2.             Hologic, Inc.

13.3.             Janssen Diagnostics, LLC

13.4.             Myriad Genetics, Inc.

13.5.             Qiagen N.V.

13.6.             Roche Diagnostics

13.7.             Siemens Healthineers

13.8.             Sysmex Corporation

13.9.             Thermo Fisher Scientific, Inc.

13.10.          AB SCIEX

13.11.          Agilent Technologies Inc.

13.12.          Abbott Laboratories

13.13.          Becton, Dickinson and Company (BD)

13.14.          Biocartis SA

13.15.          Biocare Medical, LLC

13.16.          bioMérieux SA

13.17.          Bio-Rad Laboratories, Inc.

13.18.          Cancer Genetics, Inc.

13.19.          Danaher Corporation

13.20.          Other Prominent Players

14.Key Strategic Recommendations

 

 

* Financial information of non-listed Companies will be provided as per availability

 

**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.

 

 

List of Figures

 

Fig: Global Cancer Diagnostics Segmentation

 

Fig: Global Cancer Diagnostics Market Value Chain Analysis,

 

Fig: Company Market Share Analysis, 2020

 

Fig: Global Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: Global Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027

 

Fig: Global Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027

 

Fig: Global Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Global Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: North America Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: North America Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027

 

Fig: North America Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027

 

Fig: North America Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027

 

Fig: North America Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: Europe Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: Europe Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027

 

Fig: Europe Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027

 

Fig: Europe Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Europe Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: the Asia-Pacific Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: the Asia-Pacific Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027

 

Fig: the Asia-Pacific Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027

 

Fig: the Asia-Pacific Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027

 

Fig: the Asia-Pacific Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: Latin America Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: Latin America Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027

 

Fig: Latin America Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027

 

Fig: Latin America Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Latin America Cancer Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: Middle East & Africa Cancer Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: Middle East & Africa Cancer Diagnostics Market Share (%), By Type, By Value, 2017-2027

 

Fig: Middle East & Africa Cancer Diagnostics Market Share (%), By Application, By Value, 2017-2027

 

Fig: Middle East & Africa Cancer Diagnostics Market Share (%), By End-User, By Value, 2017-2027

 

Fig: Middle East & Africa Cancer Diagnostics Market Share (%), By Region, By Value, 2017-2027

 

 

 

 

List of Tables

 

Table: Global Cancer Diagnostics Market Size, By Type, By Value, 2017-2027

 

Table: Global Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027

 

Table: Global Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027

 

Table: Global Cancer Diagnostics Market Size, By Region, By Value (USD Million), 2017-2027

 

Table: North America Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027

 

Table: North America Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027

 

Table: North America Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027

 

Table: North America Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027

 

Table: Europe Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027

 

Table: Europe Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027

 

Table: Europe Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027

 

Table: Europe Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027

 

Table: Latin America Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027

 

Table: Latin America Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027

 

Table: Latin America Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027

 

Table: Latin America Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Cancer Diagnostics Market Size, By Type, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Cancer Diagnostics Market Size, By Application, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Cancer Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Cancer Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027

 

Table: Hologic, Inc. Financial Analysis

Table: Hologic, Inc. Business Overview

Table: GE Healthcare Financial Analysis

Table: GE Healthcare Business Overview

Table: Janssen Diagnostics LLC Financial Analysis

Table: Janssen Diagnostics LLC Business Overview

Table: Myriad Genetics, Inc. Limited Financial Analysis

Table: Myriad Genetics, Inc. Limited Business Overview

Table: Qiagen N.V. Financial Analysis

Table: Qiagen N.V. Business Overview

Table: Roche Diagnostics Financial Analysis

Table: Roche Diagnostics Business Overview

Table: Siemens Healthineers Financial Analysis

Table: Siemens Healthineers Business Overview

Table: Sysmex Corporation Financial Analysis

Table: Sysmex Corporation Business Overview

Table: Thermo Fisher Scientific, Inc. Financial Analysis

Table: Thermo Fisher Scientific, Inc. Business Overview

Table: AB SCIEX Financial Analysis

Table: AB SCIEX Business Overview

Table: Agilent Technologies Inc. Financial Analysis

Table: Agilent Technologies Inc. Business Overview

Table: Abbott Laboratories Corporation Financial Analysis

Table: Abbott Laboratories Corporation Business Overview

Table: Becton, Dickinson, and Company (BD) Financial Analysis

Table: Becton, Dickinson, and Company (BD) Business Overview

Table: Biocartis SA Financial Analysis

Table: Biocartis SA Business Overview

Table: Biocare Medical, LLC Financial Analysis

Table: Biocare Medical, LLC Business Overview

Table: bioMérieux SA Financial Analysis

Table: bioMérieux SA Business Overview

Table: Bio-Rad Laboratories, Inc. Financial Analysis

Table: Bio-Rad Laboratories, Inc. Business Overview

Table: Cancer Genetics, Inc. Financial Analysis

Table: Cancer Genetics, Inc. Business Overview

Table: Danaher Corporation Financial Analysis

Table: Danaher Corporation Business Overview

 

WHY CHOOSE US

  • 24/7 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Coustom Research Service

    Ask the Analyst to customize an exclusive study to serve your research needs.

  • Quality & Accuracy

    offers best quality reports based on various authentic and accurate data findings.

  • Data Visualization

    As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization

  • Information security

    We never share your personal and confidential information. Your personal information is safe and secure with us.